Stockscreener 앱 받기
97.66
0.19%
0.2212
전일 마감가:
$97.44
열려 있는:
$97.72
하루 거래량:
2.07M
Relative Volume:
0.23
시가총액:
$248.54B
수익:
$63.17B
순이익/손실:
$12.15B
주가수익비율:
54.26
EPS:
1.8
순현금흐름:
$14.84B
1주 성능:
-0.75%
1개월 성능:
-8.20%
6개월 성능:
-25.34%
1년 성능:
-4.49%
1일 변동 폭
$96.95
$98.43
1주일 범위
$94.48
$98.84
52주 변동 폭
$94.48
$134.63
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
MRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| MRK | 97.63 | 248.54B | 63.17B | 12.15B | 14.84B | 1.80 |
| LLY | 741.77 | 693.54B | 40.86B | 8.37B | -2.28B | 5.4193 |
| NVO | 102.25 | 465.74B | 39.36B | 13.79B | 9.83B | 2.4077 |
| JNJ | 153.40 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
| ABBV | 168.76 | 294.70B | 55.53B | 5.12B | 15.62B | 3.65 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
L & S Advisors Inc Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Holdings Cut by Mizuho Securities USA LLC - MarketBeat
Massachusetts Financial Services Co. MA Has $975.97 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Integrated Investment Consultants LLC - MarketBeat
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist - The Motley Fool
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Trustmark National Bank Trust Department - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 142,958 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Intech Investment Management LLC Raises Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
King Luther Capital Management Corp Purchases 44,795 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Citizens Financial Group Inc. RI Has $27.79 Million Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Ontario Teachers Pension Plan Board Sells 7,664 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jennison Associates LLC Sells 728,756 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care - Yahoo Finance
Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio - Insider Monkey
Merck: to present its advances in hematology at ASH - Marketscreener.com
Payden & Rygel Grows Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Moran Wealth Management LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Grandfield & Dodd LLC - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Sells 792,148 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Commerce Bank Buys 29,422 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Prospera Private Wealth LLC Buys 12,781 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Cut by Northwest Bancshares Inc. - MarketBeat
Strategy Asset Managers LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Quest Partners LLC Has $1.18 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck says Keytruda injection on par with approved IV version in trial - Reuters
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
Merck & Co.’s Subcutaneous Keytruda Matches I.V. - Citeline News & Insights
Merck & Co., Inc. (NYSE:MRK) Raises Dividend to $0.81 Per Share - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.1%Here's Why - MarketBeat
Merck readies new Keytruda version ahead of major regulatory headwinds - Seeking Alpha
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients - Yahoo Finance
Merck & Co. Raises Quarterly Dividend by 5.2% - Marketscreener.com
Merck Increases Quarterly Dividend to $0.81 Per Share, Payable Jan. 8 to Shareholders of Record Dec. 16 - Marketscreener.com
Merck Declares $0.81 Per Share Q1 2025 Dividend, Sets January Payment Date | MRK Stock News - StockTitan
New Millennium Group LLC Has $1.27 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
PNC Financial Services Group Inc. Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Makes New $42.43 Million Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: success of a subcutaneous version of Keytruda - Marketscreener.com
Fifth Third Wealth Advisors LLC Buys 34,312 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Prospera Financial Services Inc Purchases 9,387 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Boosted by Smead Capital Management Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Meeder Asset Management Inc. - MarketBeat
Merck stock gains on injectable Keytruda trial win (MRK:NYSE) - Seeking Alpha
Pathstone Holdings LLC Sells 7,059 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Belmont Capital LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’ - Insider Monkey
Merck & Co. Inc. stock rises Monday, still underperforms market - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Trading Down 0.6%What's Next? - MarketBeat
Stocks Flash: Biggest Recent Disappointment (Merck & Co Inc., MRK) and Biggest Bright Spot (Dell Technologies Inc, DELL) - Elliott Wave International
Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now? - Insider Monkey
Braun Stacey Associates Inc. Sells 7,853 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.20%
0.93%
자본화:
|
볼륨(24시간):